H.I.G. Capital Makes Strategic Equity Investment in Rising Pharmaceuticals

H.I.G. Capital Acquires Aspire Pharma Limited

September 24, 2021

Pharmaceuticals

An affiliate of H.I.G. Capital has acquired Aspire Pharma Limited, a UK-based developer and licensor of niche generic and branded specialty pharmaceuticals. Founder Graham Fraser-Pye remains with the business as chairman; financial terms were not disclosed and H.I.G. said it will support Aspire's organic growth, M&A activity and international expansion.

H.I.G. Capital Makes Strategic Growth Investment in 3Pillar Global

November 23, 2021

Software

H.I.G. Capital (through an affiliate) made a strategic growth investment in 3Pillar Global, a global software product development firm. The investment will support 3Pillar's continued scaling, talent attraction and development, and expansion of its digital product engineering capabilities.

H.I.G. Capital Makes $225M Strategic Minority Investment in eHealth, Inc.

May 17, 2021

Healthcare Services

An affiliate of H.I.G. Capital completed a $225 million strategic minority investment in eHealth, Inc. via convertible preferred stock. The capital will be used to accelerate eHealth's growth, expand scale and market share, and fast-track the company's strategic initiatives for its online health insurance marketplace.

H.I.G. Capital Acquires ITH Group Limited

June 13, 2025

Healthcare Services

H.I.G. Capital (via an affiliate) has completed the acquisition of ITH Group Limited, a UK-based provider of aseptic pharmaceutical compounding services. Financial terms were not disclosed; ITH's founders Adam Bloom and Karen Hamling will remain in management as H.I.G. supports organic growth and increased production capacity.

1315 Capital Backs USpharma Ltd. with Growth Equity Investment

June 30, 2025

Pharmaceuticals

USpharma Ltd., a Miami Lakes-based pharmaceutical development and manufacturing company, received a growth equity investment from Philadelphia-based 1315 Capital. The capital will be used to accelerate development and commercialization of USpharma’s pipeline, expand commercial reach, and scale operations at its 150,000 sq. ft. US-based GMP facility.

H.I.G. Capital Invests in Medusind Solutions

April 11, 2019

Healthcare Services

H.I.G. Capital (through an affiliate) completed a strategic investment in Medusind Solutions, a Miami-based provider of revenue cycle management and practice management software. The investment is intended to accelerate Medusind's growth — both organically and via add-on acquisitions — and support continued product and service expansion.